Results 181 to 190 of about 11,802 (200)

Carbapenem resistance in Enterobacterales: Predicting clinical outcomes in bloodstream infections

Indian Journal of Medical Microbiology
Carbapenem-resistant Enterobacterales (CRE) are a global concern due to their high mortality rates and limited therapeutics. CRE-caused bloodstream infections (BSIs) are challenging to manage, especially in healthcare settings. This study aimed to investigate the predictors of mortality in BSI patients caused by CRE.A single center prospective study to
openaire   +2 more sources

Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

EClinicalMedicine, 2023
Biljana Carevic, Gorana Dragovac, Maria Paniagua   +2 more
exaly  

The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgery

Clinical Microbiology and Infection, 2021
Jean-Paul Lellouche, Amir Nutman, Elizabeth Temkin   +2 more
exaly  

Multicenter study on the prevalence of colonization due to carbapenem-resistant Enterobacterales strains before and during the first year of COVID-19, Italy 2018–2020

Frontiers in Public Health, 2023
TERESA Fasciana, Anna Giammanco, TERESA Fasciana   +2 more
exaly  

Risk factors for carbapenem‐resistant Enterobacterales infection among hospitalized patients with previous colonization

Journal of Clinical Laboratory Analysis, 2022
Mao Zhou, Qun Yan, Zijuan Jian
exaly  

Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan

Journal of Global Antimicrobial Resistance, 2022
Keisuke Oka, Nobuyuki Tetsuka, Hiroshi Morioka   +2 more
exaly  

The first nationwide surveillance of carbapenem-resistant Enterobacterales in the United Arab Emirates – increased association of Klebsiella pneumoniae CC14 clone with Emirati patients

International Journal of Infectious Diseases, 2022
Agnes Sonnevend, Akela Ghazawi, Jens Thomsen   +2 more
exaly  

Real-world clinical outcomes of meropenem/vaborbactam for treatment of carbapenem-resistant Enterobacterales infections

Journal of Global Antimicrobial Resistance, 2021
Helen L Zhang, Leigh Cressman, Ebbing Lautenbach   +2 more
exaly  

Impact of a Rapid Molecular Test for Klebsiella pneumoniae Carbapenemase and Ceftazidime-Avibactam Use on Outcomes After Bacteremia Caused by Carbapenem-Resistant Enterobacterales

Clinical Infectious Diseases, 2022
Michael J Satlin, Liang Chen, Jamie Marino   +2 more
exaly  

Assessment of Mortality-Related Risk Factors and Effective Antimicrobial Regimens for Treatment of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacterales

Antimicrobial Agents and Chemotherapy, 2021
Liang Chen, Xiudi Han, Minghui Li
exaly